A groundbreaking gene therapy has shown it can slow the progression of Huntington's disease by 75% in a small clinical trial. This one-time treatment could reshape the future for patients with this rare brain disorder.
New research reveals that silencing hyperactive AgRP neurons in the brain could reverse type 2 diabetes without affecting weight or diet. This groundbreaking study challenges existing beliefs and points to new treatment avenues.
A team of scientists at Johns Hopkins Medicine has unveiled how glutamate activates brain receptors using advanced cryo-EM imaging, paving the way for novel treatments for epilepsy and other neurological conditions.
